Koninklijke Philips N.V. (PHG)
NYSE: PHG · Real-Time Price · USD
28.93
-0.73 (-2.46%)
At close: Mar 6, 2026, 4:00 PM EST
29.00
+0.07 (0.24%)
After-hours: Mar 6, 2026, 7:15 PM EST

Company Description

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally.

It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices.

It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health.

The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013.

Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Koninklijke Philips N.V.
Koninklijke Philips logo
Country Netherlands
Founded 1891
Industry Medical Devices
Sector Healthcare
Employees 65,340
CEO Roy W. Jakobs

Contact Details

Address:
Philips Center, Prinses Irenestraat 59
Amsterdam, 1077 WV
Netherlands
Phone 31 20 597 7777
Website philips.com

Stock Details

Ticker Symbol PHG
Exchange NYSE
Fiscal Year January - December
Reporting Currency EUR
CIK Code 0000313216
CUSIP Number 500472303
ISIN Number US5004723038
SIC Code 3844

Key Executives

Name Position
Henk Siebren de Jong Executive Vice President and Chief Executive Officer of Domestic Appliances
Roy W. O. Jakobs President, Chief Executive Officer and Chairman of the Board of Management
Dr. Paulus A. Stoffels M.D., Ph.D. Independent Vice Chairman of Supervisory Board and Secretary
Charlotte Hanneman Executive Vice President, Chief Financial Officer and Member of Board of Management
Marnix J. van Ginneken Ph.D. Executive Vice President, Chief ESG and Legal Officer and Member of the Board of Management
Willem Appelo Executive Vice President and Chief Operating Officer
Durga Doraisamy Head of Investor Relations
Heidi Sichien Executive Vice President and Chief People Officer
Dr. Jan Kimpen M.D., Ph.D. Chief Medical Officer
Pim Preesman Country Leader/ Health Systems Leader Indonesia

Latest SEC Filings

Date Type Title
Feb 19, 2026 20-F Annual and transition report of foreign private issuers
Feb 19, 2026 6-K Report of foreign issuer
Feb 10, 2026 6-K Report of foreign issuer
Feb 10, 2026 6-K Report of foreign issuer
Nov 4, 2025 6-K Report of foreign issuer
Jul 29, 2025 6-K Report of foreign issuer
Jun 5, 2025 6-K Report of foreign issuer
Jun 4, 2025 6-K Report of foreign issuer
May 28, 2025 SD Form - SD
May 16, 2025 6-K Report of foreign issuer